Cargando…
Role of non-coding RNAs and RNA modifiers in cancer therapy resistance
As the standard treatments for cancer, chemotherapy and radiotherapy have been widely applied to clinical practice worldwide. However, the resistance to cancer therapies is a major challenge in clinics and scientific research, resulting in tumor recurrence and metastasis. The mechanisms of therapy r...
Autores principales: | Zhang, Xinyi, Xie, Kai, Zhou, Honghua, Wu, Yuwei, Li, Chan, Liu, Yating, Liu, Zhaoya, Xu, Qian, Liu, Shuang, Xiao, Desheng, Tao, Yongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050132/ https://www.ncbi.nlm.nih.gov/pubmed/32122355 http://dx.doi.org/10.1186/s12943-020-01171-z |
Ejemplares similares
-
A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis
por: Wang, Zuli, et al.
Publicado: (2021) -
The chromatin-associated RNAs in gene regulation and cancer
por: Tang, Jun, et al.
Publicado: (2023) -
Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer
por: Liu, Hongyu, et al.
Publicado: (2018) -
DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
por: Chen, Ling, et al.
Publicado: (2019) -
Inhibition of RNF182 mediated by Bap promotes non-small cell lung cancer progression
por: Liu, Yating, et al.
Publicado: (2023)